Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018:1074:465-471.
doi: 10.1007/978-3-319-75402-4_57.

Brain-Derived Neurotrophic Factor as a Treatment Option for Retinal Degeneration

Conor Daly  1 , Rebecca Ward  1 , Alison L Reynolds  2 , Orla Galvin  1   3 , Ross F Collery  4 , Breandán N Kennedy  5
Affiliations
Review

Brain-Derived Neurotrophic Factor as a Treatment Option for Retinal Degeneration

Conor Daly et al. Adv Exp Med Biol. 2018.

Abstract

This review discusses the therapeutic potential of brain-derived neurotrophic factor (BDNF) for retinal degeneration. BDNF, nerve growth factor (NGF), neurotrophin 3 (NT-3) and NT-4/NT-5 belong to the neurotrophin family. These neuronal modulators activate a common receptor and a specific tropomyosin-related kinase (Trk) receptor. BDNF was identified as a photoreceptor protectant in models of retinal degeneration as early as 1992. However, development of effective therapeutics that exploit this pathway has been difficult due to challenges in sustaining therapeutic levels in the retina.

Keywords: BDNF; Brain-Derived Neurotrophic Factor; Neuroprotection; Photoreceptor; Retinal degeneration.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources